Research and Industrial Center Borschahivka chemical and pharmaceutical plant (Kyiv) has won a tender of the United Nations Development Program (UNDP) to supply anti-tuberculosis medicine Rifampicinum using budget funds. According to the contract signed by the plant and the UNDP, the total amount of medicines worth UAH 6 million is to be handed over to the international organization no later than January 2019.
“The victory of the enterprise in the tender confirms that any pharmaceutical manufacturer that is able to provide high-quality products at an affordable price has a chance to win. We have already delivered the first batch of drugs for tuberculosis treatment in the tender,” the press service reported, citing Director General Yulia Zdarevska.
As reported, Borschahivka chemical and pharmaceutical plant in 2017 won the tender of UNDP for the supply of two anti-tuberculosis drugs Rifampicinum and Aethambutolum for UAH 3.6 million.
ANTI-TUBERCULOSIS MEDICINE, BORSCHAHIVKA CHEMICAL PLANT, TENDER, UNDP
